A Phase I Randomised, Double-Blind, Placebo-Controlled, Single and Multiple Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Food Effect of WD-910 in Healthy Participants

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2025
This is a phase I, randomised, double-blind, placebo-controlled, 3-part study to evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics and food effect of WD-910 in in Healthy Participants Detailed
Epistemonikos ID: c3001c650866c5c492b999ea6814ca2d659c6169
First added on: Mar 28, 2025